CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

2 weeks to go..., page-13

  1. 166 Posts.
    lightbulb Created with Sketch. 5
    The risk is clearly on the downside. If the drug is rejected initially - the price falls to twenty cents. If the drug is accepted, the market then starts to focus on the low probability that biotechs face in actually making money from a drug.

    I think the current price is a good risk / reward to SELL.
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.